Incidence and Clinical Implications of Placenta Accreta Spectrum after Treatment for Asherman Syndrome

被引:8
|
作者
Tavcar, Jovana [1 ,3 ,4 ]
Movilla, Peter [1 ]
Carusi, Daniela A. [2 ]
Loring, Megan [1 ]
Reddy, Himabindu [2 ]
Isaacson, Keith [1 ]
Morris, Stephanie N. [1 ]
机构
[1] Mass Gen Brigham, Newton Wellesley Hosp, Ctr Minimally Invas Gynecol Surg, Newton, MA USA
[2] Mass Gen Brigham, Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA USA
[3] Medstar Georgetown Univ Hosp, Washington, DC USA
[4] Medstar Georgetown Univ Hosp, 3800 Reservoir Rd, Washington, DC 20007 USA
关键词
Abnormal placentation; Hysteroscopy; Intrauterine adhesions; ABNORMALLY INVASIVE PLACENTA; CONSERVATIVE MANAGEMENT; ADHERENT PLACENTA; MORBIDITY; OUTCOMES; PREVIA;
D O I
10.1016/j.jmig.2022.11.013
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Study Objective: To investigate the incidence, predictors, and clinical implications of placenta accreta spectrum (PAS) in pregnancies after hysteroscopic treatment for Asherman syndrome (AS).Design: This is a retrospective cohort study, conducted through a telephone survey and chart review.Setting: Minimally invasive gynecologic surgery center in an academic community hospital.Patients: Database of 355 patients hysteroscopically treated for AS over 4 years. We identified patients who achieved preg-nancy past the first trimester and evaluated the incidence and predictors for PAS as well as associated clinical implications.Interventions: Telephone survey.Measurements and Main Results: We identified 97 patients meeting the inclusion criteria. Among these patients, 23 (23.7%) patients had PAS. History of cesarean delivery was the only variable statistically significantly associated with having PAS (adjusted odds ratio 4.03, 95% confidence interval 1.31-12.39). PAS was diagnosed antenatally in 3 patients (14.3%), with patients having placenta previa more likely to be diagnosed (p <.01). Nine patients (39.13%) with PAS required cesarean hysterectomy, which is 9.3% of those with a pregnancy that progressed past the first trimester. Factors associated with cesarean hysterectomy were the eti-ology of AS (dilation and evacuation after the second trimester pregnancy or postpartum instrumentation, p <.01), invasive placenta (increta or percreta, p <.05), and history of morbidly adherent placenta in previous pregnancies (p <.05). Two patients with PAS (9.5%) had uterine rupture, and another 2 (9.5%) experienced uterine inversion.Conclusion: There is a high incidence of PAS and associated morbidity in pregnancies after hysteroscopic treatment for AS. There is a low rate of antenatal diagnosis as well as a lack of reliable clinical predictors, which both stress the importance of clinical awareness, careful counseling, and delivery planning. Journal of Minimally Invasive Gynecology (2023) 30, 192 -198.(c) 2022 AAGL. All rights reserved.
引用
收藏
页码:192 / 198
页数:7
相关论文
共 50 条
  • [21] The use of methotrexate in conservative treatment of placenta accreta spectrum disorders
    Gregoir, Caroline
    De Becker, Ben
    Hauspy, Jan
    Vanderheyden, Tina
    Loquet, Philip
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2022, 35 (25): : 7514 - 7517
  • [22] Effectiveness of segmental resection technique in the treatment of placenta accreta spectrum
    Cirpan, Teksin
    Akdemir, Ali
    Okmen, Firat
    Hortu, Ismet
    Ekici, Huseyin
    Imamoglu, Metehan
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2021, 34 (19): : 3227 - 3233
  • [23] PLACENTA ACCRETA FOLLOWING HYSTEROSCOPIC LYSIS OF ADHESIONS CAUSED BY ASHERMAN'S SYNDROME: A CASE REPORT AND LITERATURE REVIEW
    不详
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2019, 123 (02): : 287 - 287
  • [24] Placenta accreta risk-antepartum score in predicting clinical outcomes of placenta accreta spectrum: A multicenter validation study
    Shazly, Sherif A.
    Anan, Mohamed A.
    Makukhina, Tatiana B.
    Melekoglu, Rauf
    Ahmed, Farhat Ul A.
    Pinto, Pedro, V
    Takahashi, Hironori
    Ahmed, Nermeen B.
    Sayed, Esraa G.
    Elassall, Gena M.
    Said, Aliaa E.
    Fahmy, Mohamed S.
    Dawyee, Diaa M.
    Penzhoyan, Gregory A.
    Amirkhanyan, Arpine M.
    Yilmaz, Ercan
    Celik, Nesibe Z.
    Aziz, Hijab
    Akhter, Tayyaba
    Ambreen, Afshan
    Abdelbadie, Amr S.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2022, 158 (02) : 424 - 431
  • [25] ASSOCIATED CLINICAL RISK FACTORS FOR PLACENTA ACCRETA SPECTRUM IN PATIENTS WITHOUT PLACENTA PREVIA
    Kita, Tomomi
    Imafuku, Hitomi
    Masuko, Naohisa
    Deguchi, Masashi
    Terai, Yoshito
    Tanimura, Kenji
    PLACENTA, 2024, 154 : 232 - 232
  • [26] Live births after Asherman syndrome treatment
    Hanstede, Miriam M. F.
    van der Meij, Eva
    Veersema, Sebastiaan
    Emanuel, Mark Hans
    FERTILITY AND STERILITY, 2021, 116 (04) : 1181 - 1187
  • [27] Maternal Outcome After Conservative Treatment of Placenta Accreta
    Sentilhes, Loic
    Ambroselli, Clemence
    Kayem, Gilles
    Provansal, Magali
    Fernandez, Herve
    Perrotin, Franck
    Winer, Norbert
    Pierre, Fabrice
    Benachi, Alexandra
    Dreyfus, Michel
    Bauville, Estelle
    Mahieu-Caputo, Dominique
    Marpeau, Loic
    Descamps, Philippe
    Goffinet, Francois
    Bretelle, Florence
    OBSTETRICS AND GYNECOLOGY, 2010, 115 (03): : 526 - 534
  • [28] Reply to Interpregnancy interval: attention should be given after conservative treatment of placenta accreta spectrum
    Zhao, Huidan
    Zhao, Xianlan
    AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2024, 6 (06)
  • [29] Maternal Outcome After Conservative Treatment of Placenta Accreta
    Chabrot, Pascal
    Diop, Abdoulaye N.
    Boyer, Louis
    Gallot, Denis
    OBSTETRICS AND GYNECOLOGY, 2010, 116 (05): : 1219 - 1220
  • [30] Placenta accreta spectrum: clinical and sonographic characteristics associated with predictive ability
    Greenberg, Victoria R.
    Lundsberg, Lisbet S.
    Kohari, Katherine
    Merriam, Audrey
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (01) : S586 - S586